Reports
Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.
Global Active Pharmaceutical Ingredients Market: By Drug Type: Innovative, Generic Active Pharmaceutical Ingredients; By Type of Manufacturer; By Type of Synthesis; By Therapeutic Application; Regional Analysis; Historical Market and Forecast (2018-2028); Market Dynamics; Competitive Landscape; Industry Events and Developments
Global Active Pharmaceutical Ingredients Market Outlook
The global active pharmaceutical ingredients market reached a value of about USD 185 billion in 2020. The market is further expected to grow at a CAGR of about 5.5% in the forecast period between 2021 and 2026 to reach USD 255 billion by 2026.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The active pharmaceutical ingredients market, catalysed by lower prices, has slowly shifted from the historical leaders of western nations to manufacturers in developing countries like China and India. For a range of large and small suppliers, the global active pharmaceutical ingredients market is highly competitive. Companies involved in its production typically specialise in their manufacturing processes and plan their production on the basis of a combination of internal competencies and business possibilities.
Market Segmentation
Active pharmaceutical component (API) refers to the biologically active ingredient of a medicine. Generally, a medicine consists of several components, where the primary component is the API. Other additives are typically known as excipients. Often a drug may include many APIs, and its effect on a patient is dependent on the prescription dosage and may differ from person to person. In combination therapy, two or more active drugs are used to treat various symptoms in multiple ways.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
On the basis of drug type, the market can be divided into the following:
- Innovative
- Generic
Based on the type of manufacturer, the industry is further segmented into:
- Captive
- Merchant API
Merchant API manufacturers can be further divided into innovative merchant API manufacturers and generic merchant API manufacturers. Based on the type of synthesis, the market can be divided into synthetic and biotech active pharmaceutical ingredients.
On the basis of type, the synthetic active pharmaceutical ingredients can be segmented into innovative synthetic APIs and generic synthetic APIs.
Biotech active pharmaceutical ingredients can be further categorised on the basis of type, product, and expression system. Based on type, the market can be divided as follows:
- Innovative Biotech APIs
- Biosimilars
On the basis of the product, the industry is segmented into the following:
- Monoclonal Antibodies
- Vaccines
- Cytokines
- Fusion Proteins
- Therapeutic Enzymes
- Blood Factors
Based on expression system, the biotech active pharmaceutical ingredients segment can be divided as follows:
- Mammalian Expression Systems
- Microbial Expression Systems
- Yeast Expression Systems
- Transgenic Animal Systems
- Others
Based on therapeutic application, the market can be segmented as follows:
- Oncology
- Cardiovascular and Respiratory Disorders
- Diabetes
- Central Nervous System Disorders
- Neurological Disorders
- Others
The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market Analysis
The rising proliferation of chronic conditions has led to a rise in drug demand and, thus, to an increase in the global active pharmaceutical ingredients market. In addition, some manufacturers are investing in R&D activities in order to offer higher quality, low-cost APIs, which can help cure illnesses outside the reach of small molecular medicinal products. Therefore, pharmaceutical firms move their manufacturing facilities to developing economies and outsource their operations to maximize production and increase input costs. In addition, there is likely to be a substantial increase in the market for generic APIs as a result of a loss of patent rights for blockbuster drugs worth several billion dollars over the next few years.
The growing number of blockbusters patent expiries is among the key drivers of this industry and provides a substantial chance to generic active pharmaceutical ingredients. In addition, the demand for active pharmaceutical ingredients for bio-based substances has been rising. The global biologics market is currently showing a strong growth, which is catalysed by its high power and ability to treat diseases other than small molecule medicines. This has led to a high demand for APIs and their biosimilar versions of marketed biological drugs. The ageing population, higher expenditure on healthcare, and increased prevalence of lifestyle diseases are the other factors that are catalysing the market.
Competitive Landscape
The report gives a detailed analysis of the following key players in the global active pharmaceutical ingredients market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
- Pfizer, Inc.
- Novartis International AG
- Teva Pharmaceutical Industries Ltd.
- Abbvie Inc
- Others
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2022 |
| Historical Period | 2018-2022 |
| Forecast Period | 2023-2028 |
| Scope of the Report | Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Drug Type, Type of Manufacturer, Type of Synthesis, Therapeutic Application, Region |
| Breakup by Drug Type | Innovative Active Pharmaceutical Ingredients, Generic Active Pharmaceutical Ingredients |
| Breakup by Type of Manufacturer | Captive Manufacturers, Merchant API Manufacturers |
| Breakup by Type of Synthesis | Synthetic Active Pharmaceutical Ingredients, Biotech Active Pharmaceutical Ingredients |
| Breakup by Therapeutic Application | Oncology, Cardiovascular and Respiratory Disorders, Diabetes, Central Nervous System Disorders, Neurological Disorders, Others |
| Breakup by Region | North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
| Market Dynamics | SWOT, Porter's Five Forces, Key Indicators for Price and Demand |
| Competitive Landscape | Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications |
| Companies Covered | Pfizer, Inc., Novartis International AG, Teva Pharmaceutical Industries Ltd., Abbvie Inc, Others |
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Industry Opportunities and Challenges
8 Global Active Pharmaceutical Ingredients Market Analysis
8.1 Key Industry Highlights
8.2 Global Active Pharmaceutical Ingredients Historical Market (2018-2022)
8.3 Global Active Pharmaceutical Ingredients Market Forecast (2023-2028)
8.4 Global Active Pharmaceutical Ingredients Market by Drug Type
8.4.1 Innovative Active Pharmaceutical Ingredients
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2018-2022)
8.4.1.3 Forecast Trend (2023-2028)
8.4.2 Generic Active Pharmaceutical Ingredients
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2018-2022)
8.4.2.3 Forecast Trend (2023-2028)
8.5 Global Active Pharmaceutical Ingredients Market by Type of Manufacturer
8.5.1 Captive Manufacturers
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2018-2022)
8.5.1.3 Forecast Trend (2023-2028)
8.5.2 Merchant API Manufacturers
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2018-2022)
8.5.2.3 Forecast Trend (2023-2028)
8.5.2.4 Breakup by Type
8.5.2.4.1 Innovative Merchant API Manufacturers
8.5.2.4.2 Generic Merchant API Manufacturers
8.6 Global Active Pharmaceutical Ingredients Market by Type of Synthesis
8.6.1 Synthetic Active Pharmaceutical Ingredients
8.6.1.1 Market Share
8.6.1.2 Historical Trend (2018-2022)
8.6.1.3 Forecast Trend (2023-2028)
8.6.1.4 Breakup by Type
8.6.1.4.1 Innovative Synthetic APIs
8.6.1.4.2 Generic Synthetic APIs
8.6.2 Biotech Active Pharmaceutical Ingredients
8.6.2.1 Market Share
8.6.2.2 Historical Trend (2018-2022)
8.6.2.3 Forecast Trend (2023-2028)
8.6.2.4 Breakup by Type
8.6.2.4.1 Innovative Biotech APIs
8.6.2.4.2 Biosimilars
8.6.2.5 Breakup by Product
8.6.2.5.1 Monoclonal Antibodies
8.6.2.5.2 Vaccines
8.6.2.5.3 Cytokines
8.6.2.5.4 Fusion Proteins
8.6.2.5.5 Therapeutic Enzymes
8.6.2.5.6 Blood Factors
8.6.2.6 Market by Expression System
8.6.2.6.1 Mammalian Expression Systems
8.6.2.6.2 Microbial Expression Systems
8.6.2.6.3 Yeast Expression Systems
8.6.2.6.4 Transgenic Animal Systems
8.6.2.6.5 Others
8.7 Global Active Pharmaceutical Ingredients Market by Therapeutic Application
8.7.1 Oncology
8.7.2 Cardiovascular and Respiratory Disorders
8.7.3 Diabetes
8.7.4 Central Nervous System Disorders
8.7.5 Neurological Disorders
8.7.6 Others
8.8 Global Active Pharmaceutical Ingredients Market by Region
8.8.1 Market Share
8.8.1.1 North America
8.8.1.2 Europe
8.8.1.3 Asia Pacific
8.8.1.4 Latin America
8.8.1.5 Middle East and Africa
9 Regional Analysis
9.1 North America
9.1.1 Historical Trend (2018-2022)
9.1.2 Forecast Trend (2023-2028)
9.1.3 Breakup by Country
9.1.3.1 United States of America
9.1.3.2 Canada
9.2 Europe
9.2.1 Historical Trend (2018-2022)
9.2.2 Forecast Trend (2023-2028)
9.2.3 Breakup by Country
9.2.3.1 United Kingdom
9.2.3.2 Germany
9.2.3.3 France
9.2.3.4 Italy
9.2.3.5 Others
9.3 Asia Pacific
9.3.1 Historical Trend (2018-2022)
9.3.2 Forecast Trend (2023-2028)
9.3.3 Breakup by Country
9.3.3.1 China
9.3.3.2 Japan
9.3.3.3 India
9.3.3.4 ASEAN
9.3.3.5 Australia
9.3.3.6 Others
9.4 Latin America
9.4.1 Historical Trend (2018-2022)
9.4.2 Forecast Trend (2023-2028)
9.4.3 Breakup by Country
9.4.3.1 Brazil
9.4.3.2 Argentina
9.4.3.3 Mexico
9.4.3.4 Others
9.5 Middle East and Africa
9.5.1 Historical Trend (2018-2022)
9.5.2 Forecast Trend (2023-2028)
9.5.3 Breakup by Country
9.5.3.1 Saudi Arabia
9.5.3.2 United Arab Emirates
9.5.3.3 Nigeria
9.5.3.4 South Africa
9.5.3.5 Others
10 Market Dynamic s
10.1 SWOT Analysis
10.1.1 Strengths
10.1.2 Weaknesses
10.1.3 Opportunities
10.1.4 Threats
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyer’s Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 Key Indicators for Demand
10.4 Key Indicators for Price
11 Value Chain Analysis
12 Manufacturing Process
12.1 Overview
12.2 Detailed Process Flow
12.3 Operations Involved
13 Competitive Landscape
13.1 Market Structure
13.2 Key Players
13.3 Company Profiles
13.3.1 Pfizer, Inc.
13.3.1.1 Company Overview
13.3.1.2 Product Portfolio
13.3.1.3 Demographic Reach and Achievements
13.3.1.4 Certifications
13.3.2 Novartis International AG
13.3.2.1 Company Overview
13.3.2.2 Product Portfolio
13.3.2.3 Demographic Reach and Achievements
13.3.2.4 Certifications
13.3.3 Teva Pharmaceutical Industries Ltd.
13.3.3.1 Company Overview
13.3.3.2 Product Portfolio
13.3.3.3 Demographic Reach and Achievements
13.3.3.4 Certifications
13.3.4 Abbvie Inc
13.3.4.1 Company Overview
13.3.4.2 Product Portfolio
13.3.4.3 Demographic Reach and Achievements
13.3.4.4 Certifications
13.3.5 Others
14 Industry Events and Developments
List of Key Figures and Tables
1. Global Active Pharmaceutical Ingredients Market: Key Industry Highlights, 2018 and 2028
2. Global Active Pharmaceutical Ingredients Historical Market: Breakup by Drug Type (USD Billion), 2018-2022
3. Global Active Pharmaceutical Ingredients Market Forecast: Breakup by Drug Type (USD Billion), 2023-2028
4. Global Active Pharmaceutical Ingredients Historical Market: Breakup by Type of Manufacturer (USD Billion), 2018-2022
5. Global Active Pharmaceutical Ingredients Market Forecast: Breakup by Type of Manufacturer (USD Billion), 2023-2028
6. Global Active Pharmaceutical Ingredients Historical Market: Breakup by Type of Synthesis (USD Billion), 2018-2022
7. Global Active Pharmaceutical Ingredients Market Forecast: Breakup by Type of Synthesis (USD Billion), 2023-2028
8. Global Active Pharmaceutical Ingredients Historical Market: Breakup by Therapeutic Application (USD Billion), 2018-2022
9. Global Active Pharmaceutical Ingredients Market Forecast: Breakup by Therapeutic Application (USD Billion), 2023-2028
10. Global Active Pharmaceutical Ingredients Historical Market: Breakup by Region (USD Billion), 2018-2022
11. Global Active Pharmaceutical Ingredients Market Forecast: Breakup by Region (USD Billion), 2023-2028
12. North America Active Pharmaceutical Ingredients Historical Market: Breakup by Country (USD Billion), 2018-2022
13. North America Active Pharmaceutical Ingredients Market Forecast: Breakup by Country (USD Billion), 2023-2028
14. Europe Active Pharmaceutical Ingredients Historical Market: Breakup by Country (USD Billion), 2018-2022
15. Europe Active Pharmaceutical Ingredients Market Forecast: Breakup by Country (USD Billion), 2023-2028
16. Asia Pacific Active Pharmaceutical Ingredients Historical Market: Breakup by Country (USD Billion), 2018-2022
17. Asia Pacific Active Pharmaceutical Ingredients Market Forecast: Breakup by Country (USD Billion), 2023-2028
18. Latin America Active Pharmaceutical Ingredients Historical Market: Breakup by Country (USD Billion), 2018-2022
19. Latin America Active Pharmaceutical Ingredients Market Forecast: Breakup by Country (USD Billion), 2023-2028
20. Middle East and Africa Active Pharmaceutical Ingredients Historical Market: Breakup by Country (USD Billion), 2018-2022
21. Middle East and Africa Active Pharmaceutical Ingredients Market Forecast: Breakup by Country (USD Billion), 2023-2028
22. Global Active Pharmaceutical Ingredients Market Structure
Key Questions Answered in the Report
In 2020, the global active pharmaceutical ingredients market attained a value of nearly USD 185 billion.
In the forecast period of 2023-2028, the market is expected to grow at a CAGR of 5.5%.
By 2026, the market is expected to attain a value of USD 255 billion.
The major drivers of the industry, such as the rising demand from the emerging nations, growing biologics market, increasing healthcare expenditure, and the rising R&D investments, are aiding the growth of the market.
The key trend guiding the growth of the market includes the upcoming expiry of blockbuster drugs patents, which provides a significant growth potential for generic active pharmaceutical ingredients.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The major drug types in the industry are innovative and generic active pharmaceutical ingredients.
The significant types of manufacturers of the product in the industry are captive and merchant API.
The leading types of synthesis of the product in the industry are synthetic and biotech active pharmaceutical ingredients.
The significant therapeutic applications of the product in the industry are oncology, cardiovascular and respiratory disorders, diabetes, central nervous system disorders, and neurological disorders, among others.
The major players in the industry are Novartis International AG, Teva Pharmaceutical Industries Ltd., and Abbvie Inc, among others.
Analyst Review
The global active pharmaceutical ingredients market attained a value of USD 185 billion in 2020, driven by the growing expenditure on healthcare. Aided by rising demand for generic APIs, the market is expected to witness a further growth in the forecast period of 2023-2028, growing at a CAGR of 5.5%. The market is projected to reach USD 255 billion by 2026.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on its drug types, the market can be segmented into innovative and generic active pharmaceutical ingredients. On the basis of types of manufacturers, the market can be divided into captive and merchant API. By types of synthesis, the industry is bifurcated into synthetic and biotech active pharmaceutical ingredients. Oncology, cardiovascular and respiratory disorders, diabetes, central nervous system disorders, and neurological disorders, among others, are the major therapeutic applications of the product in the industry. The major regional markets for active pharmaceutical ingredients are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific. The key players in the above market include Novartis International AG, Teva Pharmaceutical Industries Ltd., and Abbvie Inc, among others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$1499
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateSingle User License
$2699-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next Update
Five User License
$3699-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$4699-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Contact AnalystAny Question? Speak With An Analyst
Request SampleView A Sample
Request CustomisationDid You Miss Anything, Ask Now
Why Expert Market Research?Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
Similar Reports
NEWSLETTER